Nasdaq: BMRN
BioMarin Pharmaceutical insiders
The officers, directors and 10% owners of BioMarin Pharmaceutical Inc. who hold the most stock, valued at the live BMRN price.
$61.42
BMRN today −$10K (−0.02%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 9
- Their BMRN stock
- $101M
- Market value
- $11.90B
- Held by ranked insiders
- 0.85%
Insiders by value of BMRN holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Jean Jacques Bienaime | Director | 721,225 | $44.3M | 0.37% | 2620th |
| 2 | Alexander Hardy | Chief Executive Officer | 214,635 | $13.2M | 0.11% | 7132nd |
| 3 | Henry J. Fuchs | President, Worldwide R&D | 185,074 | $11.4M | <0.1% | 7977th |
| 4 | Richard A. Meier | Director | 126,926 | $7.8M | <0.1% | 10566th |
| 5 | Brian Mueller | EVP, Chief Financial Officer | 123,314 | $7.6M | <0.1% | 10767th |
| 6 | Elaine J. Heron | Director | 97,720 | $6.0M | <0.1% | 6862nd |
| 7 | Charles Greg Guyer | EVP, Chief Technical Officer | 84,140 | $5.2M | <0.1% | 14136th |
| 8 | David E. I. Pyott | Director | 49,750 | $3.1M | <0.1% | 9651st |
| 9 | Elizabeth M. Anderson | Director | 41,940 | $2.6M | <0.1% | 5432nd |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for BioMarin Pharmaceutical; see each profile for the filing.